{"database": "lobbying", "table": "lobbying_activities", "rows": [[1407070, "088f1f11-3a05-424e-a07f-0086be958115", "Q2", "PHILIP W. JOHNSTON ASSOCIATES", 400278335, "LUMARA HEALTH (FKA KV PHARMACEUTICAL COMPANY)", 2013, "second_quarter", "PHA", "Legislation regulating compounding pharmacies to improve patient safety.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2013-07-15T14:46:46.017000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1407070"], "units": {}, "query_ms": 6.030210992321372, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}